Customized research for ARPO vs. GLYC!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. GLYC.


↗ Join Our Free Email Newsletter.




Aerpio Pharmaceuticals Inc. vs. GlycoMimetics, Inc.

Industry Match! Industry of Both ARPO and GLYC:

Health Care/Life Sciences

ARPO
Data Last Updated: 5 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 38.964M


P/E: N/A

P/S: 1.93

Q P/B: 0.77

Y Rev: 20.16M

Q Rev: -

Beta: N/A

ARPO Share Stats

Outstanding Shares

40.59M

Float Shares

28.06M

Percent of Float Short

0.44%

ARPO Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

27.00

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial...

ARPO Financials

Annual Financials

Income Statement

Revenue

20.16M

Net Income

(10.4M)

Cash Flow Statement

Change in Cash / Investments

42.35M

Balance Sheet

Cash / Investments

62.61M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

63.98M

Total Current Liabilities

5.46M

Total Assets

64.12M

Total Liabilities

5.46M

Stockholder Equity

58.67M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(8.49M)

Cash Flow Statement

Q Change in Cash / Investments

(9.19M)

Balance Sheet

Q Cash / Investments

53.42M

Q Short Term Debt

189,511

Q Long Term Debt

None

Q Total Current Assets

54.3M

Q Total Current Liabilities

3.92M

Q Total Assets

55.06M

Q Total Liabilities

4.26M

Q Stockholder Equity

50.8M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

GLYC
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 504.788M


P/E: N/A

P/S: N/A

Q P/B: 2.62

Y Rev: -

Q Rev: -

Beta: 2.38

GLYC Share Stats

Outstanding Shares

43.17M

Float Shares

33.48M

Percent of Float Short

16.99%

GLYC Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

GLYC Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

GLYC in Pulse Portal

Stream of Posts

GLYC Symbol Page

Share GLYC Insights

Express Sentiment

'Buy' or 'Sell' GLYC

GLYC Profile

CEO

Mr. Timothy R. Pearson

Exchange

Nasdaq

Employees

50.00

About

GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary...

GLYC Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(48.27M)

Cash Flow Statement

Change in Cash / Investments

85.99M

Balance Sheet

Cash / Investments

209.92M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

212.27M

Total Current Liabilities

8.76M

Total Assets

214.84M

Total Liabilities

9.37M

Stockholder Equity

205.46M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(14.08M)

Cash Flow Statement

Q Change in Cash / Investments

(14.36M)

Balance Sheet

Q Cash / Investments

195.56M

Q Short Term Debt

739,930

Q Long Term Debt

None

Q Total Current Assets

198.39M

Q Total Current Liabilities

8.31M

Q Total Assets

204.44M

Q Total Liabilities

11.65M

Q Stockholder Equity

192.79M

GLYC Charts

10-Year Chart

GLYC 10-Year Chart

5-Year Chart

GLYC 5-Year Chart

1-Year Chart

GLYC 1-Year Chart

6-Month Chart

GLYC 6-Month Chart

3-Month Chart

GLYC 3-Month Chart

1-Month Chart

GLYC 1-Month Chart

1-Day Chart

GLYC 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon